[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Habal et al., 1972 - Google Patents

Renal allografting in the patient with juvenile diabetes mellitus

Habal et al., 1972

Document ID
8921620973992212742
Author
Habal M
Birtch A
Kountz S
Stephans B
Murray J
Publication year
Publication venue
The American Journal of Surgery

External Links

Snippet

A case is presented to illustrate the change in our thinking regarding allotransplantation in patients with terminal juvenile diabetic nephropathy. The absence of any histopathologic changes in the first renal allograft after 704 days of transplantation encouraged us to …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations

Similar Documents

Publication Publication Date Title
Woodruff et al. Homotransplantation of kidney in patients treated by preoperative local irradiation and postoperative administration of an antimetabolite (Imuran): report of six cases
Veith et al. Lung transplantation 1983
Gliedman et al. Pancreatic duct to ureter anastomosis for exocrine drainage in pancreatic transplantation
Najarian et al. Protection of the donor kidney during homotransplantation.
Starzl History of liver and other splanchnic organ transplantation
Sass et al. Liver and kidney transplantation: a half-century historical perspective
Starzl et al. Liver Transplantation in the Ciclosporin Era1
DZIK et al. Cyclosporine-associated thrombotic thrombocytopenic purpura following liver transplantation–successful treatment with plasma exchange
Calne et al. Renal transplantation in man
Agarwal et al. Recurrent hemolytic uremic syndrome in an adult renal allograft recipient: current concepts and management.
Dealy Jr et al. Total body irradiation in man: tissue patterns observed in attempts to increase the receptivity of renal homografts
Giordano Preservation of adrenocortical function during surgery for bilateral pheochromocytoma
Moseley et al. Immunologic relationships between skin and kidney homografts in dogs on immunosuppressive therapy
Habal et al. Renal allografting in the patient with juvenile diabetes mellitus
Lang et al. Liver transplantation in a child with sickle cell anemia
Richter et al. Action of Human “Pernicious Anemia Liver Extract.”
MARYNIAK et al. RECURRENCE OF DIABETIC NODULAR: GLOMERULOSCLEROSIS IN A RENAL TRANSPLANT
Goss et al. Aplastic anemia complicating orthotopic liver transplantation
Lucas et al. Renal allotransplantation in man: II. Transplantation in cystinosis, a metabolic disease
GOLDEN et al. Immune-related renal vein thrombosis in a renal allograft
Starzl et al. Perspectives in organ transplantation.
Iguchi et al. Plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis of kidney allograft in adult recipients
US20240000908A1 (en) Method for Treating Antibody-Mediated Rejection
Jovanovic-Peterson et al. Studies of human fetal pancreatic allografts in diabetic recipients without immunosuppression
Starzl et al. The history of pancreas transplantation